A message from CEO
“molmir” is a coined word with the meaning of looking at molecules. By capturing the movement of molecules at the atomic level, we will develop treatment methods for intractable diseases including ALS (amyotrophic lateral sclerosis). We will develop treatment methods for intractable diseasesincluding ALS and present new possibilities for drug discovery from Japan to the world.
June 21, 2022
Venture from Academia（3 institutional accreditations）
Mormil Co., Ltd. is a venture company certified by Nara Medical University, National Institute of Advanced Industrial Science and Technology, AIST, and Tokushima University. They were registered as accredited ventures in June 2022 (No. 5), July 2022 (No. 153), and August 2022 (No. 31), respectively. In the future, we will continue to cooperate with various research institutes and aim to stand as a “human resource platform (infrastructure/receptacle) for Japanese science and technology”.
A member list（January 13, 2023）
Eiichiro Mori （CEO・Nara Medical University） Masataka Yamamoto（COO） Kota Togami （CFO） Shunsuke Tomita （Scientific Advisor・AIST） Tomohide Saio （Scientific Advisor・Tokushima University）